Literature DB >> 6299919

Clonidine and GH secretion in insulin dependent diabetes (IDD).

G Speroni, G P Ceda, L Capretti, G Valenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6299919     DOI： 10.1055/s-2007-1018623

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  4 in total

1.  Clinical and pharmacological characterization of anomalous metoclopramide-induced growth hormone secretion in insulin-dependent diabetes mellitus.

Authors:  F Caviezel; G Lepore; M L Maglio; M Croci; G Comi; L Morricone
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

2.  Inappropriate growth-hormone (GH) response to thyrotropin-releasing hormone (TRH) occurs infrequently in well-regulated diabetes mellitus.

Authors:  O Giampietro; M Ferdeghini; R Miccoli; G Gregori; G Penno; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1990 Apr-Jun

3.  The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitus.

Authors:  R M Williams; R Amin; F Shojaee-Moradie; A M Umpleby; C L Acerini; D B Dunger
Journal:  Diabetologia       Date:  2003-07-24       Impact factor: 10.122

Review 4.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.